IMA NASDAQ
ImageneBio Inc
1W: -2.5%
1M: -7.3%
3M: -23.3%
YTD: -31.9%
1Y: -46.0%
3Y: -91.3%
5Y: -97.0%
$4.60
+0.02 (+0.43%)
Weekly Expected Move ±3.9%
$4
$4
$5
$5
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
12 relationships12
As Filer
counterparties named
0
As Counterparty
mentioned by others
5
Rel. Types
2023-08-07
Earliest Filing
2025-10-29
Latest Filing
target: 3
partner: 3
supplier: 2
customer: 2
acquirer: 2
Counterparties (Filed by IMA)
12 relationshipsCompanies named in IMA's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Miragene Inc. | — | supplier | Transition services agreement regarding chemistry, manufacturing, controls, and translational sciences research | 2025-10-29 | View |
| Inmagene Biopharmaceuticals | — | target | Target company in the merger with Ikena Oncology, Inc. | 2025-07-29 | View |
| Hutchmed Limited | — | partner | Counterparty to the collaboration, option and license agreement for OX40 receptor mAb. | 2025-07-29 | View |
| WuXi Biologics | — | supplier | Counterparty to the Cell Line License Agreement for manufacturing technology. | 2025-07-29 | View |
| Miragene Inc | — | customer | Counterparty to the Transition Services Agreement and recipient of the Non-OX40 Business divestiture. | 2025-07-29 | View |
| Miragene Co | — | customer | Counterparty that purchased SellCo in the Non-OX40 Divestiture. | 2025-07-29 | View |
| Inmagene Biopharmaceuticals | — | target | Target company in the merger agreement with Ikena Oncology, Inc. | 2024-12-23 | View |
| Insight Merger Sub I | — | acquirer | Wholly owned subsidiary of Ikena used as the merger vehicle. | 2024-12-23 | View |
| Insight Merger Sub II | — | acquirer | Wholly owned subsidiary of Ikena used as the second merger vehicle. | 2024-12-23 | View |
| Pionyr Immunotherapeutics, Inc. | — | target | Target company acquired by Ikena Oncology, Inc. in a merger agreement dated August 4, 2023. | 2023-08-07 | View |
| Fortis Advisors LLC | — | partner | Securityholder agent appointed in the Agreement and Plan of Merger. | 2023-08-07 | View |
| Computershare Trust Company N.A | — | partner | Rights agent appointed in the Contingent Value Rights Agreement. | 2023-08-07 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-05 | Earnings Release; Exhibits | View | |
| 2026-07-23 | Officer/Director Change; Other Events; Exhibits | View | |
| 2026-06-26 | Officer/Director Change | View | |
| 2026-06-17 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-04-13 | Material Agreement; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-03-17 | Departure/Election of Directors; Appointment of Officers | View | |
| 2026-03-10 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-02-17 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-12-18 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-11-19 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-05 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-10-29 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement | Agreement | View |
| 2025-10-22 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-10-10 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-08-12 | Completion of Acquisition or Disposition of Assets; Financial Statements and Exhibits | Acquisition | View |
| 2025-08-05 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2025-08-01 | Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh | View | |
| 2025-07-29 | Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregi | Agreement Acquisition | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR